secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2026-08-26T19:10:39+00:00
Accession:  0001493152-26-040216
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen shareholders approve 100M share increase to 2024 incentive plan and written consent amendment
--------------------------------------------------------------------------------

- Stockholders approved Plan Amendment increasing shares available under 2024 Omnibus Incentive Plan by 100,000,000 to 102,800,000 initial limit.
- Approved charter amendment permitting stockholder action by written consent, effective Aug 26, 2026.
- Elected Dr. Keow Lin Goh and Victor Sordillo as Class II directors for three-year terms.
- Ratified KPMG LLP as independent auditor for fiscal year ending Dec 31, 2026.
- Votes: Plan Amendment 5,322,668 for; charter amendment 5,382,051 for; quorum 5,956,141 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315226040216/0001493152-26-040216-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315226040216/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-040216

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer